rs747685252
Positions:
Variant summary
Our verdict is Pathogenic. Variant got 14 ACMG points: 14P and 0B. PVS1_StrongPM2PP5_Very_Strong
The NM_012210.4(TRIM32):βc.691delGβ(p.Ala231fs) variant causes a frameshift change. The variant allele was found at a frequency of 0.0000273 in 1,613,948 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Likely pathogenic (β β ).
Frequency
Genomes: π 0.0000066 ( 0 hom., cov: 33)
Exomes π: 0.000029 ( 0 hom. )
Consequence
TRIM32
NM_012210.4 frameshift
NM_012210.4 frameshift
Scores
Not classified
Clinical Significance
Conservation
PhyloP100: 6.48
Genes affected
TRIM32 (HGNC:16380): (tripartite motif containing 32) The protein encoded by this gene is a member of the tripartite motif (TRIM) family. The TRIM motif includes three zinc-binding domains, a RING, a B-box type 1 and a B-box type 2, and a coiled-coil region. The protein localizes to cytoplasmic bodies. The protein has also been localized to the nucleus, where it interacts with the activation domain of the HIV-1 Tat protein. The Tat protein activates transcription of HIV-1 genes. [provided by RefSeq, Jul 2008]
ASTN2 (HGNC:17021): (astrotactin 2) This gene encodes a protein that is expressed in the brain and may function in neuronal migration, based on functional studies of the related astrotactin 1 gene in human and mouse. A deletion at this locus has been associated with schizophrenia. Multiple transcript variants encoding different proteins have been found for this locus. [provided by RefSeq, May 2010]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Pathogenic. Variant got 14 ACMG points.
PVS1
Loss of function variant, product does not undergo nonsense mediated mRNA decay. Variant is located in the 3'-most exon, not predicted to undergo nonsense mediated mRNA decay. There are 13 pathogenic variants in the truncated region.
PM2
Very rare variant in population databases, with high coverage;
PP5
Variant 9-116698432-TG-T is Pathogenic according to our data. Variant chr9-116698432-TG-T is described in ClinVar as [Likely_pathogenic]. Clinvar id is 498076.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr9-116698432-TG-T is described in Lovd as [Pathogenic]. Variant chr9-116698432-TG-T is described in Lovd as [Pathogenic].
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
TRIM32 | NM_012210.4 | c.691delG | p.Ala231fs | frameshift_variant | 2/2 | ENST00000450136.2 | NP_036342.2 | |
ASTN2 | NM_001365068.1 | c.2806+27338delC | intron_variant | ENST00000313400.9 | NP_001351997.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
TRIM32 | ENST00000450136.2 | c.691delG | p.Ala231fs | frameshift_variant | 2/2 | 1 | NM_012210.4 | ENSP00000408292.1 | ||
ASTN2 | ENST00000313400.9 | c.2806+27338delC | intron_variant | 5 | NM_001365068.1 | ENSP00000314038.4 |
Frequencies
GnomAD3 genomes AF: 0.00000658 AC: 1AN: 152078Hom.: 0 Cov.: 33
GnomAD3 genomes
AF:
AC:
1
AN:
152078
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.0000239 AC: 6AN: 251376Hom.: 0 AF XY: 0.0000294 AC XY: 4AN XY: 135860
GnomAD3 exomes
AF:
AC:
6
AN:
251376
Hom.:
AF XY:
AC XY:
4
AN XY:
135860
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0000294 AC: 43AN: 1461870Hom.: 0 Cov.: 30 AF XY: 0.0000330 AC XY: 24AN XY: 727234
GnomAD4 exome
AF:
AC:
43
AN:
1461870
Hom.:
Cov.:
30
AF XY:
AC XY:
24
AN XY:
727234
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.00000658 AC: 1AN: 152078Hom.: 0 Cov.: 33 AF XY: 0.00 AC XY: 0AN XY: 74260
GnomAD4 genome
AF:
AC:
1
AN:
152078
Hom.:
Cov.:
33
AF XY:
AC XY:
0
AN XY:
74260
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Bravo
AF:
ClinVar
Significance: Pathogenic/Likely pathogenic
Submissions summary: Pathogenic:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | Eurofins Ntd Llc (ga) | Oct 21, 2016 | - - |
Limb-girdle muscular dystrophy Pathogenic:1
Likely pathogenic, criteria provided, single submitter | clinical testing | Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine | Jul 31, 2017 | The p.Ala231GlnfsX21 (NM_012210.3 c.691delG) variant in TRIM32 has not been prev iously reported in the literature. It has been identified in 1/22,296 Finnish ch romosomes by the Genome Aggregation Database (http://gnomad.broadinstitute.org; rs747685252).This variant is predicted to cause a frameshift, which alters the p rotein?s amino acid sequence beginning at position 231 and leads to a premature termination codon 21 amino acids downstream. This alteration is then predicted t o lead to a truncated or absent protein. Biallelic loss of function of the TRIM3 2 gene has been associated with limb girdle muscular dystropy. In summary, altho ugh additional studies are required to fully establish a null effect on the prot ein, the p.Ala231GlnfsX21 variant is likely pathogenic for limb girdle muscular dystrophy in an autosomal recessive manner based on its predicted impact on the protein. - |
Bardet-Biedl syndrome Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Dec 07, 2023 | This sequence change creates a premature translational stop signal (p.Ala231Glnfs*21) in the TRIM32 gene. While this is not anticipated to result in nonsense mediated decay, it is expected to disrupt the last 423 amino acid(s) of the TRIM32 protein. This variant is present in population databases (rs747685252, gnomAD 0.004%). This premature translational stop signal has been observed in individual(s) with non-syndromic retinitis pigmentosa (PMID: 35055178). ClinVar contains an entry for this variant (Variation ID: 498076). This variant disrupts a region of the TRIM32 protein in which other variant(s) (p.Val591Met) have been determined to be pathogenic (PMID: 30823891). This suggests that this is a clinically significant region of the protein, and that variants that disrupt it are likely to be disease-causing. For these reasons, this variant has been classified as Pathogenic. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at